These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 27396756

  • 1. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H, Shang C, Wang M, Shen T, Kong L, Yu C, Ye Z, Luo Y, Liu L, Li Y, Huang S.
    Biochem Pharmacol; 2016 Sep 15; 116():39-50. PubMed ID: 27396756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y, Xu S, Lin J, Yao G, Han Z, Liang B, Zou Z, Chen Z, Song Q, Dai Y, Gao T, Liu A, Bai X.
    Breast Cancer Res Treat; 2012 Nov 15; 136(2):379-88. PubMed ID: 23053656
    [Abstract] [Full Text] [Related]

  • 5. Dihydroartemisinin Inhibits mTORC1 Signaling by Activating the AMPK Pathway in Rhabdomyosarcoma Tumor Cells.
    Luo J, Odaka Y, Huang Z, Cheng B, Liu W, Li L, Shang C, Zhang C, Wu Y, Luo Y, Yang S, Houghton PJ, Guo X, Huang S.
    Cells; 2021 Jun 01; 10(6):. PubMed ID: 34205996
    [Abstract] [Full Text] [Related]

  • 6. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
    Huang Y, Xi Q, Chen Y, Wang J, Peng P, Xia S, Yu S.
    Anticancer Drugs; 2013 Oct 01; 24(9):889-98. PubMed ID: 23838676
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
    Pantovic A, Bosnjak M, Arsikin K, Kosic M, Mandic M, Ristic B, Tosic J, Grujicic D, Isakovic A, Micic N, Trajkovic V, Harhaji-Trajkovic L.
    Int J Biochem Cell Biol; 2017 Feb 01; 83():84-96. PubMed ID: 27988363
    [Abstract] [Full Text] [Related]

  • 12. Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells.
    Chen L, Xu B, Liu L, Luo Y, Yin J, Zhou H, Chen W, Shen T, Han X, Huang S.
    Lab Invest; 2010 May 01; 90(5):762-73. PubMed ID: 20142804
    [Abstract] [Full Text] [Related]

  • 13. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S, Bell CM, Rothbart SB, Moran RG.
    J Biol Chem; 2015 Nov 13; 290(46):27473-86. PubMed ID: 26391395
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM, Evangelisti C, Chappell W, Abrams SL, Bäsecke J, Stivala F, Donia M, Fagone P, Nicoletti F, Libra M, Ruvolo V, Ruvolo P, Kempf CR, Steelman LS, McCubrey JA.
    Leukemia; 2011 Jul 13; 25(7):1064-79. PubMed ID: 21436840
    [Abstract] [Full Text] [Related]

  • 17. Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer.
    Yang F, Deng R, Qian XJ, Chang SH, Wu XQ, Qin J, Feng GK, Ding K, Zhu XF.
    Cell Death Dis; 2014 Mar 13; 5(3):e1114. PubMed ID: 24625973
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q, Qin S, Zhang H, Liu B, Qin J, Wang X, Zhang R, Liu C, Dong X, Zhang S, Huang S, Chen L.
    J Cell Physiol; 2018 Jan 13; 233(1):516-529. PubMed ID: 28300280
    [Abstract] [Full Text] [Related]

  • 19. Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion.
    Chen L, Xu B, Liu L, Liu C, Luo Y, Chen X, Barzegar M, Chung J, Huang S.
    Oncotarget; 2015 Mar 30; 6(9):7136-50. PubMed ID: 25762619
    [Abstract] [Full Text] [Related]

  • 20. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W, Ye Q, Liu S, She QB.
    Oncotarget; 2015 Jun 10; 6(16):13962-77. PubMed ID: 25961827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.